Plaque progression: Where, why, and how fast? A review of what we have learned from the analysis of patient data from the PARADIGM registry

J Cardiovasc Comput Tomogr. 2022 Jul-Aug;16(4):294-302. doi: 10.1016/j.jcct.2021.11.004. Epub 2021 Nov 14.

Abstract

Ischemic heart disease is the most common cause of mortality worldwide. The pathophysiology of myocardial infarction relates to temporal changes of atherosclerotic plaque culminating in plaque rupture, erosion or hemorrhage and the subsequent thrombotic response. Coronary computed tomographic angiography (CCTA) provides the ability to visualize and quantify plaque, and plaque progression can be measured on a per-patient basis by comparing findings of serial CCTA. The Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry was established with the objective of identifying patterns of plaque progression in a large population. The registry comprises over 2000 patients with multiple CCTA scans performed at least two years apart. Unlike previous CCTA registries, a semi-automated plaque quantification technique permitting detailed analysis of plaque progression was performed on all patients with interpretable studies. Since the registry was established, 19 peer-reviewed publications were identified, and all are reviewed and summarized in this article.

Keywords: Atherosclerosis; Coronary computed tomography angiography coronary artery disease; Myocardial infarction.

Publication types

  • Review

MeSH terms

  • Computed Tomography Angiography / methods
  • Coronary Angiography / methods
  • Coronary Artery Disease* / diagnostic imaging
  • Disease Progression
  • Humans
  • Plaque, Atherosclerotic*
  • Predictive Value of Tests
  • Prospective Studies
  • Registries